Fecha de publicación: 18/03/2015 Fuente: WIPO "royal jelly" The invention discloses a composition for treating hyperlipidaemia. In order to fully exert the medicinal values of royal jelly acid or royal jelly acid derivatives and ginkgo leaf, according to the adopted technical scheme, the composition comprises royal jelly acid or royal jelly acid derivatives and ginkgo leaf, when the ginkgo leaf is an extract, a weight part ratio of the royal jelly acid or royal jelly acid derivatives to the ginkgo leaf is (1-10):(1-25), and when the ginkgo leaf is a crushed object, a weight part ratio of the royal jelly acid or royal jelly acid derivatives to the ginkgo leaf is (1-10):(1-100). According to the invention, the respective effects of the royal jelly acid or royal jelly acid derivatives and the ginkgo leaf are exerted, a synergistic effect can be achieved, the hyperlipidaemia can be effectively treated, lipid metabolism of the body is improved, and the lip decomposition process is promoted, so that the fat accumulation in the body is reduced, the growth process of lipomatosis is delayed or reversed, and atherosclerosishardening of the arteries, cardiovascular and cerebrovascular diseases and stroke caused by hyperlipidaemia are prevented.